Lantheus Holdings Inc (NASDAQ:LNTH) Shares Sold by South Dakota Investment Council

South Dakota Investment Council reduced its stake in Lantheus Holdings Inc (NASDAQ:LNTH) by 39.0% in the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 13,600 shares of the medical equipment provider’s stock after selling 8,700 shares during the period. South Dakota Investment Council’s holdings in Lantheus were worth $385,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors also recently made changes to their positions in LNTH. Mason Street Advisors LLC grew its stake in shares of Lantheus by 3.6% during the first quarter. Mason Street Advisors LLC now owns 12,380 shares of the medical equipment provider’s stock valued at $303,000 after acquiring an additional 435 shares in the last quarter. State Board of Administration of Florida Retirement System grew its stake in shares of Lantheus by 5.3% during the second quarter. State Board of Administration of Florida Retirement System now owns 12,522 shares of the medical equipment provider’s stock valued at $354,000 after acquiring an additional 630 shares in the last quarter. Arizona State Retirement System grew its stake in shares of Lantheus by 1.3% during the second quarter. Arizona State Retirement System now owns 60,218 shares of the medical equipment provider’s stock valued at $1,704,000 after acquiring an additional 752 shares in the last quarter. TD Asset Management Inc. grew its stake in shares of Lantheus by 1.4% during the second quarter. TD Asset Management Inc. now owns 63,009 shares of the medical equipment provider’s stock valued at $1,783,000 after acquiring an additional 900 shares in the last quarter. Finally, Texas Permanent School Fund grew its stake in shares of Lantheus by 4.0% during the first quarter. Texas Permanent School Fund now owns 26,173 shares of the medical equipment provider’s stock valued at $641,000 after acquiring an additional 1,002 shares in the last quarter. Hedge funds and other institutional investors own 95.73% of the company’s stock.

NASDAQ:LNTH traded up $0.55 during mid-day trading on Friday, reaching $24.58. The stock had a trading volume of 7,699 shares, compared to its average volume of 275,368. The company has a market capitalization of $869.96 million, a price-to-earnings ratio of 26.20, a price-to-earnings-growth ratio of 1.87 and a beta of 1.50. Lantheus Holdings Inc has a 1-year low of $12.59 and a 1-year high of $29.80. The stock’s 50 day simple moving average is $22.62 and its two-hundred day simple moving average is $24.74. The company has a debt-to-equity ratio of 2.05, a current ratio of 2.62 and a quick ratio of 2.01.

Lantheus (NASDAQ:LNTH) last posted its quarterly earnings results on Thursday, July 25th. The medical equipment provider reported $0.27 EPS for the quarter, hitting the Zacks’ consensus estimate of $0.27. The business had revenue of $85.70 million during the quarter, compared to the consensus estimate of $88.72 million. Lantheus had a return on equity of 51.08% and a net margin of 11.20%. The company’s revenue for the quarter was up .1% compared to the same quarter last year. During the same period last year, the firm earned $0.25 earnings per share. Sell-side analysts anticipate that Lantheus Holdings Inc will post 1 EPS for the current fiscal year.

In other Lantheus news, CEO Mary Anne Heino sold 25,538 shares of the firm’s stock in a transaction dated Tuesday, September 3rd. The shares were sold at an average price of $21.21, for a total value of $541,660.98. Following the transaction, the chief executive officer now owns 597,884 shares of the company’s stock, valued at $12,681,119.64. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, SVP Michael P. Duffy sold 5,604 shares of the firm’s stock in a transaction dated Wednesday, September 4th. The stock was sold at an average price of $20.60, for a total transaction of $115,442.40. Following the completion of the transaction, the senior vice president now directly owns 138,890 shares in the company, valued at approximately $2,861,134. The disclosure for this sale can be found here. Insiders sold 111,552 shares of company stock worth $2,911,266 in the last three months. 2.60% of the stock is currently owned by corporate insiders.

Several brokerages have recently weighed in on LNTH. CJS Securities upgraded Lantheus from a “market perform” rating to an “outperform” rating in a research note on Friday, August 16th. BidaskClub upgraded Lantheus from a “hold” rating to a “buy” rating in a research note on Friday. Zacks Investment Research downgraded Lantheus from a “hold” rating to a “sell” rating in a research note on Friday, August 2nd. Finally, ValuEngine downgraded Lantheus from a “buy” rating to a “hold” rating in a research note on Thursday, August 1st. One investment analyst has rated the stock with a sell rating, one has assigned a hold rating and two have assigned a buy rating to the company’s stock. The stock has an average rating of “Hold” and a consensus price target of $29.00.

Lantheus Company Profile

Lantheus Holdings, Inc develops, manufactures, and commercializes diagnostic medical imaging agents and products that assist clinicians in the diagnosis and treatment of cardiovascular and other diseases worldwide. Its principal products include DEFINITY, a microbubble contrast agent used in ultrasound exams of the heart; and TechneLite, a technetium generator that provides the nuclear material used in nuclear medicine procedures.

Read More: What is required to own or exchange cryptocurrency?

Institutional Ownership by Quarter for Lantheus (NASDAQ:LNTH)

Receive News & Ratings for Lantheus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Lantheus and related companies with MarketBeat.com's FREE daily email newsletter.